Sara Thronburg, APRN
Primary Care · Douglas, WYNPI 1225662216
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,395 of the $2,213 with a category attached, or 63.0%. Stryker accounts for 65.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $1,708 and has fallen 83.9% since, to $275 in 2025. Among primary care clinicians in WY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $65.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Boston Scientific$353
- AbbVie$170
- Lilly USA, LLC$60
- Axsome Therapeutics, Inc.$48
- AstraZeneca$47
- plus $89 from 4 others
What the payments were for
- Travel & lodging$1,39563%
- Food & beverage$81937%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 5 | $1,447 |
| Boston Scientific | 16 | $353 |
| AbbVie | 4 | $170 |
| Lilly USA, LLC | 1 | $60 |
| Axsome Therapeutics, Inc. | 1 | $48 |
| AstraZeneca | 3 | $47 |
| Vertex | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| GSK | 1 | $20 |
| Lundbeck LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVEREST SPINAL SYSTEM$1,395
- BOTOX$110
How this compares
$2,213 in reported general payments places this provider in the 95th percentile of 24 primary care providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 45 | $1,102 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 51 | $922 |
| Cyclobenzaprine Hcl | 50 | $714 |
| Methylprednisolone | 66 | $475 |
| Cephalexin | 15 | $448 |
| Methocarbamol | 23 | $342 |
| Tizanidine Hcl | 34 | $339 |
| Tramadol Hcl | 57 | $294 |
| Doxycycline Hyclate | 23 | $279 |
| Meloxicam | 24 | $35 |
| Prednisone | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other primary care in Douglas
- Amy SmithLaramie$3K
- Nikole LawrenceGillette$587
- Jennifer WagyCasper$558
- Alexandra GebhardtCasper$539
- Ashley TupperNewcastle$423
- Venese GraunkeCasper$421
- Hope LyonGillette$370
- Loura HeuerCasper$364
- Jenae SchoenikeGillette$301
- Andrew TrunkhillCody$251
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.